Jasper Therapeutics
Price & Volume
Stats
See more52W Range | $4.55-$31.01 |
Market Cap | $89.4M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.75 |
News
See moreYahoo Finance • 13 days ago
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Yahoo Finance • 19 days ago
Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
Yahoo Finance • last year
Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria
Yahoo Finance • last year
Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
About
CEO | Mr. Ronald A. Martell |
CFO | Mr. Herbert C. Cross CPA |
Address | 2200 Bridge Pkwy, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 45 |
